Security Snapshot

NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) Institutional Ownership

CUSIP: 66987P409

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

26

Shares (Excl. Options)

6,094,463

Price

$5.64

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
NBY on NYSE
Shares outstanding
26,643,793
Price per share
$0.43
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,094,463
Total reported value
$34,376,759
% of total 13F portfolios
0%
Share change
+5,867,804
Value change
+$33,230,317
Number of holders
26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Investment Quick Answers

What is CUSIP 66987P409?
CUSIP 66987P409 identifies NBY - NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Framework Ventures IV L.P. 45% -0.22% $321,141,812 56,806,080 0% Framework Ventures IV L.P. 16 Jan 2026
R01 Fund LP 58% +29% $6,656,419 -$17,770,195 15,480,044 -73% Kazley Michael John 31 Mar 2026
Lazar David E. 5% -75% $36,028,320 +$27,556,589 6,388,000 +325% David E. Lazar 21 Oct 2025
POPLAR POINT CAPITAL MANAGEMENT LLC 0.81% -93% $673,398 1,020,300 0% Poplar Point Capital Management LLC 20 Oct 2025

As of 31 Dec 2025, 26 institutional investors reported holding 6,094,463 shares of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY). This represents 23% of the company’s total 26,643,793 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 6.9% 1,830,728 0% $10,325,306
VANGUARD GROUP INC 6.9% 1,829,223 +2065% 0% $10,316,818
GEODE CAPITAL MANAGEMENT, LLC 4.7% 1,257,705 +2332% 0% $7,097,514
STATE STREET CORP 1.2% 313,703 +971% 0% $1,769,285
NORTHERN TRUST CORP 1% 273,788 0% $1,544,164
GOLDMAN SACHS GROUP INC 0.39% 104,341 0% $588,483
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.35% 93,261 0% $525,992
JANE STREET GROUP, LLC 0.26% 70,070 0% $395,195
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.18% 46,744 0% $263,636
C2C Wealth Management, LLC 0.17% 45,000 0.21% $253,800
Qube Research & Technologies Ltd 0.15% 40,826 0% $230,259
UBS Group AG 0.13% 33,598 0% $189,493
Apollon Wealth Management, LLC 0.1% 27,561 0% 0% $155,444
Bank of New York Mellon Corp 0.1% 25,799 0% $145,507
OMERS ADMINISTRATION Corp 0.08% 21,200 0% $119,568
MORGAN STANLEY 0.08% 20,529 +684200% 0% $115,783
ExodusPoint Capital Management, LP 0.08% 20,160 0% $113,702
Compound Planning, Inc. 0.06% 16,821 0% $94,870
VICTORY CAPITAL MANAGEMENT INC 0.05% 14,354 0% $80,957
CITIGROUP INC 0.02% 4,676 +100% 0% $26,373
Tower Research Capital LLC (TRC) 0.01% 2,984 +215% 0% $16,830
BANK OF AMERICA CORP /DE/ 0% 1,197 +2394% 0% $6,751
ROYAL BANK OF CANADA 0% 190 0% $1,000
NVWM, LLC 0% 3 0% 0% $17
Addison Advisors LLC 0% 1 0% 0% $6

Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,094,463 $34,376,759 +$33,230,317 $5.64 26
2025 Q3 226,658 $289,923 +$135,649 $1.28 12
2025 Q2 218,521 $126,742 -$84,498 $0.58 11
2025 Q1 362,238 $211,908 +$113,243 $0.58 15
2024 Q4 167,029 $100,725 +$22,013 $0.60 14
2024 Q3 125,970 $87,462 +$79,537 $0.69 12
2024 Q2 11,501 $25,420 +$25,420 $2.24 7

Sponsored